Post-Authorization Study Evaluating Safety Of Tigecycline

NCT00827541 · clinicaltrials.gov ↗

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Intra-Abdominal Infections
Skin Disease, Infectious
Soft Tissues Infections

Interventions

DRUG: Tigecycline

Sponsor

Pfizer